Observational studyBMC cardiovascular disorders2026
Relationship between perioperative serum albumin levels and paravalvular leak after transcatheter aortic valve replacement.
Observational study in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundParavalvular leak (PVL) remains a significant complication after transcatheter aortic valve replacement (TAVR). This study investigated the relationship between perioperative serum albumin levels and post-TAVR paravalvular leak.
methodsThis retrospective observational study analyzed 1463 consecutive patients who underwent TAVR between 2013 and 2023. Serum albumin levels were measured preoperatively, immediately after procedure, and on postoperative days 1–5 and before discharge. Additional biomarkers including NT-proBNP and high-sensitivity troponin T were collected. Postprocedural echocardiography was used to assess PVL severity according to American Society of Echocardiography and European Association of Cardiovascular Imaging guidelines. Primary endpoints included correlation between various albumin parameters and PVL severity.
resultsThe cohort included 851 males (58.2%) and 612 females (41.8%) with a mean age of 72.5 ± 7.5 years. Serum albumin showed a characteristic decline pattern, reaching nadir immediately postoperatively (35.1 ± 4.3 g/L) and gradually recovering to 38.1 ± 4.1 g/L by discharge. Among patients with evaluable PVL (n = 717), 539 (75.2%) had no or trace PVL, 91 (12.7%) had mild PVL, and 87 (12.1%) had moderate or severe PVL. Patients with moderate or severe PVL showed greater maximum albumin decline (19.8 ± 11.2%) compared to those without significant PVL (12.4 ± 10.6%, p < 0.01). Maximum albumin decline showed the strongest correlation with PVL severity (r = 0.142, p < 0.001). ROC analysis revealed maximum albumin decline had the highest predictive value for moderate or severe PVL (AUC = 0.604), with optimal cutoff at 18.9% (sensitivity 68.6%, specificity 48.2%). Furthermore, patients with both elevated maximum albumin decline and moderate or severe PVL demonstrated significantly higher one-year mortality compared to those with preserved albumin dynamics and no significant PVL.
conclusionsPerioperative albumin dynamics, particularly maximum albumin decline, are associated with paravalvular leak after TAVR. These findings suggest albumin level changes may serve as a simple biomarker to identify patients at higher risk for significant PVL, with potential implications for clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.